home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A new program for calculation of statistical power in genetic association studies

 
  June, 12 2008 17:37
your information resource in human molecular genetics
 
     
The relation between sample sizes and statistical power is a constant issue in human molecular genetics. This relationship is not a simple one and is affected by several factors, such as number of statistical tests carried out and LD between markers. Idan Menashe et al presents in a recent paper in BMC Genetics a new freely-available program to calculate statistical power for distinct types of association studies. PGA is a program that is designed to give calculations of samples sizes required for specific statistical power values under different models, such as dominant, co-dominant or recessive effects for single SNPs or haplotypes, and for different study parameters (such as disease prevalences or allele frequencies). In addition, it is possible to obtain a minimum detectable relative risk for specific samples, which is useful for retrospective analysis of previously collected datasets.

PGA will be helpful, in addition to other available programs, such as the Power Genetic Calculator, for researchers designing and analyzing genetic association studies for a large number of human diseases and phenotypes.

Author: Idan Menashe

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institute of Health, USA

Email: menashei@mail.nih.gov

Reference:

Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for case-control genetic association analyses. BMC Genet. 2008 May 13;9:36.

Paper available online.

The PGA program is available at PGA website.


Message posted by: Diego Forero

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.